Trulieve Cannabis (CNSX:TRUL) Rises 11.5% Following Acquisition of Conditional Medical Cannabis License in Texas - What’s New?
Trulieve's Texas License Approval: Trulieve Cannabis Corp. received conditional approval for a Dispensing Organization license in Texas, allowing it to cultivate, manufacture, and distribute medical cannabis products, which could enhance its growth potential in a significant market.
Investment Outlook and Risks: While the Texas license offers a new growth avenue, Trulieve's future performance remains tied to federal policy changes and tax reforms, with current challenges including ongoing losses and margin pressures.
Revenue Projections: Trulieve aims for $1.2 billion in revenue and $15 million in earnings by 2028, necessitating modest annual growth and significant earnings recovery from current losses.
Diverse Fair Value Estimates: The community's fair value estimates for Trulieve's stock vary widely, indicating differing opinions on its worth, emphasizing the importance of considering multiple perspectives before investing.
About the author









